Ground-breaking Trial on the Benefits of Psilocybin Therapy for Alcohol Dependence Published by B.More Principal Investigator, Michael Bogenschutz
/PRNewswire/ -- B.More Inc., a 501(c)(3) non-profit, clinical-stage biopharmaceutical company focused on the development of psychedelic medicines for substance...
Source: prnewswire.com